D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 56 Citations 11,388 150 World Ranking 6958 National Ranking 3188

Overview

What is he best known for?

The fields of study he is best known for:

  • Enzyme
  • Internal medicine
  • Immune system

Donald W. MacGlashan spends much of his time researching Histamine, Immunoglobulin E, Basophil, Internal medicine and Endocrinology. Donald W. MacGlashan has included themes like Mast cell, Receptor, Leukotriene and Cell biology in his Histamine study. The concepts of his Receptor study are interwoven with issues in Leukotriene C4 and Liberation.

Immunoglobulin E is the subject of his research, which falls under Immunology. His work on Omalizumab, Allergy and Allergen as part of general Immunology study is frequently connected to Downregulation and upregulation, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them. His research in Basophil intersects with topics in Secretion, Stimulation and Interleukin 4.

His most cited work include:

  • Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. (690 citations)
  • Omalizumab-induced reductions in mast cell FcεRI expression and function (344 citations)
  • The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. (283 citations)

What are the main themes of his work throughout his whole career to date?

Histamine, Immunology, Immunoglobulin E, Basophil and Mast cell are his primary areas of study. His Histamine study incorporates themes from Molecular biology, Biochemistry and Stimulation. In most of his Immunology studies, his work intersects topics such as Receptor expression.

His Immunoglobulin E study combines topics from a wide range of disciplines, such as Receptor, Interleukin 4, Antigen and Cell biology. Donald W. MacGlashan has researched Basophil in several fields, including Secretion, Granulocyte, Leukotriene, Syk and Degranulation. His study focuses on the intersection of Endocrinology and fields such as Calcium with connections in the field of Extracellular.

He most often published in these fields:

  • Histamine (49.81%)
  • Immunology (46.30%)
  • Immunoglobulin E (46.30%)

What were the highlights of his more recent work (between 2009-2021)?

  • Immunology (46.30%)
  • Immunoglobulin E (46.30%)
  • Basophil (44.75%)

In recent papers he was focusing on the following fields of study:

Donald W. MacGlashan focuses on Immunology, Immunoglobulin E, Basophil, Histamine and Omalizumab. The Immunoglobulin E study combines topics in areas such as Receptor, Stimulation and Allergy. His Basophil research is multidisciplinary, incorporating perspectives in Receptor expression and Interleukin 4.

His Histamine research includes elements of Degranulation, Antigen and Syk. As part of one scientific family, he deals mainly with the area of Omalizumab, narrowing it down to issues related to the Food allergy, and often Basopenia. The study incorporates disciplines such as Oncology and Parenchyma in addition to Internal medicine.

Between 2009 and 2021, his most popular works were:

  • Expression of CD203c and CD63 in human basophils: relationship to differential regulation of piecemeal and anaphylactic degranulation processes (118 citations)
  • Kinetics of mast cell, basophil, and oral food challenge responses in omalizumab-treated adults with peanut allergy (102 citations)
  • IgE antibody-specific activity in human allergic disease (88 citations)

In his most recent research, the most cited papers focused on:

  • Enzyme
  • Immune system
  • Internal medicine

His primary scientific interests are in Immunology, Basophil, Immunoglobulin E, Histamine and Syk. His Immunology study which covers Receptor that intersects with Secretion, CD23 and Cell type. The various areas that he examines in his Basophil study include Mast cell, Interleukin 33, Epitope and Stimulation.

His Mast cell study combines topics in areas such as Eosinophil, Biochemistry and Chronic urticaria. His work carried out in the field of Histamine brings together such families of science as Omalizumab and Degranulation. His Syk research also works with subjects such as

  • Bruton's tyrosine kinase which is related to area like Autoantibody and Interleukin 4,
  • LYN which intersects with area such as Flow cytometry.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody.

Donald W. MacGlashan;Bruce S. Bochner;Daniel C. Adelman;Paula M. Jardieu.
Journal of Immunology (1997)

956 Citations

Omalizumab-induced reductions in mast cell FcεRI expression and function

Lisa A. Beck;Gregory V. Marcotte;Donald MacGlashan;Alkis Togias.
The Journal of Allergy and Clinical Immunology (2004)

454 Citations

The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.

Michele Columbo;Edward M. Horowitz;Luis M. Botana;Donald W. MacGlashan.
Journal of Immunology (1992)

433 Citations

Prostaglandin-Induced Activation of Nociceptive Neurons via Direct Interaction with Transient Receptor Potential A1 (TRPA1)

Thomas E. Taylor-Clark;Bradley J. Undem;Donald W. MacGlashan;Srinivas Ghatta.
Molecular Pharmacology (2008)

369 Citations

Generation of leukotrienes by purified human lung mast cells.

D W MacGlashan;R P Schleimer;S P Peters;E S Schulman.
Journal of Clinical Investigation (1982)

354 Citations

Down-Regulation of Human Basophil IgE and FCεRIα Surface Densities and Mediator Release by Anti-IgE-Infusions Is Reversible In Vitro and In Vivo

Sarbjit S. Saini;Donald W. Macglashan;Sherry A. Sterbinsky;Alkis Togias.
Journal of Immunology (1999)

297 Citations

Secretion of IL-4 from human basophils. The relationship between IL-4 mRNA and protein in resting and stimulated basophils.

Donald MacGlashan;Jane M. White;Shau Ku Huang;Santa J. Ono.
Journal of Immunology (1994)

285 Citations

Arachidonic acid metabolism in purified human lung mast cells.

S P Peters;D W MacGlashan;E S Schulman;R P Schleimer.
Journal of Immunology (1984)

280 Citations

Characteristics of human basophil sulfidopeptide leukotriene release: Releasability defined as the ability of the basophil to respond to dimeric cross-links

D W MacGlashan;S P Peters;J Warner;L M Lichtenstein.
Journal of Immunology (1986)

265 Citations

Human lung mast cells: purification and characterization.

E S Schulman;D W MacGlashan;S P Peters;R P Schleimer.
Journal of Immunology (1982)

258 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Donald W. MacGlashan

Stephen J. Galli

Stephen J. Galli

Stanford University

Publications: 86

Gianni Marone

Gianni Marone

University of Naples Federico II

Publications: 86

Bruce S. Bochner

Bruce S. Bochner

Northwestern University

Publications: 82

Lawrence M. Lichtenstein

Lawrence M. Lichtenstein

Johns Hopkins University

Publications: 75

Peter Valent

Peter Valent

Medical University of Vienna

Publications: 65

Ann M. Dvorak

Ann M. Dvorak

Beth Israel Deaconess Medical Center

Publications: 61

Robert P. Schleimer

Robert P. Schleimer

Northwestern University

Publications: 47

Anne Kagey-Sobotka

Anne Kagey-Sobotka

Johns Hopkins University

Publications: 46

Stephen T. Holgate

Stephen T. Holgate

University of Southampton

Publications: 45

Lawrence B. Schwartz

Lawrence B. Schwartz

Virginia Commonwealth University

Publications: 39

Rudolf Valenta

Rudolf Valenta

Medical University of Vienna

Publications: 39

Peter F. Weller

Peter F. Weller

Beth Israel Deaconess Medical Center

Publications: 39

Bradley J. Undem

Bradley J. Undem

Johns Hopkins University School of Medicine

Publications: 39

Robert G. Hamilton

Robert G. Hamilton

Johns Hopkins University School of Medicine

Publications: 37

Hugh A. Sampson

Hugh A. Sampson

Icahn School of Medicine at Mount Sinai

Publications: 35

Didier G. Ebo

Didier G. Ebo

University of Antwerp

Publications: 34

Trending Scientists

Gabriel Robins

Gabriel Robins

University of Virginia

George Vosselman

George Vosselman

University of Twente

Varinder K. Aggarwal

Varinder K. Aggarwal

University of Bristol

Michael W. Gray

Michael W. Gray

Dalhousie University

Ulrich Mühlenhoff

Ulrich Mühlenhoff

Philipp University of Marburg

Michael Sendtner

Michael Sendtner

University of Würzburg

Stephen M. Prescott

Stephen M. Prescott

University of Utah

Kathryn A. Eaton

Kathryn A. Eaton

University of Michigan–Ann Arbor

Martin Werner

Martin Werner

Alfred Wegener Institute for Polar and Marine Research

Baudewijntje P.C. Kreukels

Baudewijntje P.C. Kreukels

VU University Medical Center

Gregor Domes

Gregor Domes

University of Trier

Linnea C. Ehri

Linnea C. Ehri

City University of New York

Allan Siperstein

Allan Siperstein

Cleveland Clinic

Lewis C. Becker

Lewis C. Becker

Johns Hopkins University School of Medicine

Achim A. Jungbluth

Achim A. Jungbluth

Memorial Sloan Kettering Cancer Center

Peter Krustrup

Peter Krustrup

University of Southern Denmark

Something went wrong. Please try again later.